€0.486 surge: CYAD.BR (EURONEXT) Celyad Oncology +38% on high volume, Feb 2026
Celyad Oncology’s CYAD.BR stock jumped to €0.486 on 20 Feb 2026, rising +38.07% on a volume surge to 451,024 shares. The move made CYAD.BR stock one of today’s high-volume movers on EURONEXT and pushed price well above its 50-day average of €0.19. Traders reacted to clinical and funding optics, while technicals show a strong short-term trend and elevated momentum. We flag the spike for active traders and long-term investors watching upcoming catalysts and the March earnings window.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
